Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)
Status:
Completed
Trial end date:
2020-12-21
Target enrollment:
Participant gender:
Summary
Double blind, placebo controlled, randomized clinical trial to evaluate the efficacy of
ivermectin in preventing progression of disease in adult patients with early stages of
COVID-19